About this trial
This research focuses on identifying medical, social, and healthcare journey determinants associated with the evolution of quality of life in the transgender population at 12 months. To address the research question, it is planned to include 1,500 transgender individuals, among those attending healthcare professionals or associations in the French territory who have agreed to take on the role of investigators (professionals in healthcare or designated individuals within an association).
Eligibility criteria
Qualifiers
Person identifying themselves as trans
Person of legal age (≥ 18 years)
Person living in France
Person who has not expressed any opposition after receiving full information about the protocol
Disqualifiers
People who do not understand or speak French, English, Spanish or Portuguese.
Person under guardianship or curatorship, under legal protection or under safeguard of justice
Anyone who has expressed their opposition after receiving full information about the protocol.
Trial design
Treatments tested in this trial
- Not listed